Learn More
Medchemexpress LLC N-hydroxy-4-[(8-quinolinylamino)methyl]benzamide | 2151853-97-1 | 99.8% | 293.32 g·mol⁻¹ | C17H15N3O2 | 5MG

Supplier: Medchemexpress LLC HY1239765MG
MPT0G211 is a potent, orally active, and selective histone deacetylase 6 (HDAC6) inhibitor (CAS 2151853-97-1) used for preclinical research. It exhibits sub-nanomolar potency (IC50 = 0.291 nM), high selectivity for HDAC6, and reported blood-brain barrier penetration. The compound is supplied as solid quantities and as a 10 mM solution in DMSO, and is accompanied by a datasheet, SDS, and certificate of analysis for research use.
- Potent HDAC6 inhibition (IC50 = 0.291 nM).
- High selectivity for HDAC6 (>1000-fold vs other isoforms).
- Reported blood-brain barrier penetration.
- Available as solid and 10 mM solution in DMSO; common pack sizes 5 mg-100 mg.
- High reported purity (~99.8%).
- Molecular formula C17H15N3O2; molecular weight 293.32 g·mol⁻¹.
- Provided with datasheet, SDS, and certificate of analysis.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.